期刊
INFLAMMATORY BOWEL DISEASES
卷 27, 期 10, 页码 1703-1705出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izab114
关键词
immunization; preventive care; vaccination; Crohn's disease; ulcerative colitis
The recent emergency use authorization of a third COVID-19 vaccine means that most patients with inflammatory bowel disease (IBD) will soon be eligible to be vaccinated. Gastroenterology clinicians should be prepared to address patients' concerns regarding safety and efficacy of vaccines, strongly recommend vaccination, and educate patients about logistics for successful vaccination. These measures are crucial to ensure high uptake among patients with IBD.
The recent emergency use authorization of a third COVID-19 vaccine means that most patients with inflammatory bowel disease (IBD) will soon be eligible to be vaccinated. Gastroenterology clinicians should be prepared to address patients' concerns regarding safety and efficacy of vaccines. They should also strongly recommend that all their patients be vaccinated with a COVID-19 vaccine. Additionally, they should be prepared to educate patients about logistics that will result in successful vaccination completion. All these measures will be crucial to ensure high uptake among their patients with IBD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据